Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: Diagnostic and therapeutic implications

Journal of NeuroVirology

Volumn 13, Issue 4, 2007, Pages 347-352

  Virtanen, Jussi Oskari ^a,b   Farkkial M ^b   Multanen, J ^b   Uotila, L ^b   Jaaskelainen A J ^a,b   Vaheri, A ^a,b   Koskiniemi, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cerebrospinal fluid; HHV 6A; Human herpesvirus 6; Intrathecal antibody production; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ACUTE DISEASE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; LABORATORY TEST; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; SYMPTOM; VIRUS STRAIN;

HUMAN HERPESVIRUS 6;

EID: 34548660355     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701381332     Document Type: Article

References (33)

1. Ablashi, D. V., Salahuddin, S. Z., Josephs, S. F., Imam, F., Lusso, P., Gallo, R. C., Hung, C., Lemp, J. and Markham, P. D. (1987) HBLV (or HHV-6) in human cell lines. Nature, 329, p. 207.
2. Akhyani, N., Berti, R., Brennan, M. B., Soldan, S. S., Eaton, J. M., McFarland, H. F. and Jacobson, M. S. (2000) Tissue distribution and variant characterization of human herpesvirus (HHV)-6: Increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis, 182, pp. 1321-1325.
3. Alvarez-Lafuente, R., Heras, V De Las, Bartolome, M., Carcia-Montojo, M. and Arroyo, R. (2006) Human herpesvirus 6 and multiple sclerosis: A one-year follow-up study. Brain Pathol, 16, pp. 20-27.
4. Alvarez-Lafuente, R., Heras, V De Las, Bartolome, M., Picazo, J. J. and Arroyo, R. (2004) Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol, 61, pp. 1523-1527.
5. Braun, D. K., Dominiguez, G. and Pellett, P. E. (1997) Human herpesvirus 6. Clin Microbiol Rev, 10, pp. 521-567.
6. Campadelli-Fiume, G., Mirandola, P. and Menotti, L. (1999) Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis, 5, pp. 353-366.
7. Challoner, P. B., Smith, K. T., Parker, J. D., MacLeod, D. L., Coulter, S. N., Rose, T. M., Schultz, E. R., Bennett, J. L., Garber, R. L., Chang, M., Schad, P. A., Stewart, P. M., Nowinski, R. C., Brown, J. P. and Burmer, G. C. (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA, 92, pp. 7440-7444.
8. Chan, P. K., Ng, H. K., Hui, M. and Cheng, A. F. (2001) Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J Med Virol, 64, pp. 42-46.
9. Chapenko, S., Millers, A., Nora, Z., Logina, I., Kukaine, R. and Murovska, M. (2003) Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol, 69, pp. 111-117.
10. Cuomo, L., Trivedi, P., Cardillo, M. R., Gagliardi, F. M., Vecchione, A., Caruso, R., Calogero, A., Frati, L., Faggioni, A. and Ragona, G. (2001) Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol, 63, pp. 45-51.
11. Deisenhammer, F., Bartos, A., Egg, R., Gilhus, N. E., Giovannoni, G., Rauer, S., Sellebjerg, F. and EFNS Task Force (2006) Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol, 13, pp. 913-922.
12. DeLorenze, G. N., Munger, K. L., Lennette, E. T., Orentreich, N., Vogelman, J. H. and Ascherio, A. (2006) Epstein-Barr virus and multiple sclerosis. Arch Neurol, 63, pp. 839-844.
13. Derfuss, T., Hohlfeld, R. and Meinl, E. (2005) Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol, 252, pp. 968-971.
14. Friedman, J. E., Lyons, M. J., Ablashi, D. V., Whitman, J. E., Edgar, M., Koskiniemi, M., Vaheri, A. and Zabriskie, J. B. (1999) The association of the human herpesvirus-6 and MS. Mult Scler, 5, pp. 355-362.
15. Friedman, J. E., Zabriskie, J. B., Plank, C., Ablashi, D., Whitman, J., Shahan, B., Edgell, R., Shieh, M., Rapalino, O., Zimmerman, R. and Sheng, D. (2005) A randomized clinical trial of valacyclovir in multiple sclerosis. Mult Scler, 11, pp. 286-295.
16. Grigoriadis, N. and Hadjigeorgiou, G. M. (2006) Virus-mediated autoimmunity in multiple sclerosis. J Autoimmun Dis, 3, pp. 1-8.
17. Hall, C. B., Caserta, M. T., Schnabel, K. C., Boettrich, C., McDermott, M. P., Lofthus, G. K., Carnahan, J. A. and Dewhurst, S. (2004) Congenital infections with human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7). J Pediatr, 145, pp. 472-477.
18. Hall, C. B., Caserta, M. T., Schnabel, K., Long, C., Epstein, L. G., Insel, R. A. and Dewhurst, S. (1998) Persistence of human herpesvirus 6 according to site and variant: Possible greater neurotropism of variant A. Clin Infect Dis, 26, pp. 132-137.
19. Jääskelainen, A. J., Piiparinen, H., Lappalainen, M., Koskiniemi, M. and Vaheri, A. (2006) Multiplex-PCR and oligonucleotide microarray for detection of eight different herpesviruses from clinical specimens. J Clin Virol, 37, pp. 83-90.
20. Josephs, S. F., Henry, B., Balachandran, N., Strayer, D., Peterson, D., Komaroff, A. L. and Ablashi, D. V. (1991) HHV-6 reactivation in chronic fatigue syndrome. Lancet, 337, pp. 1346-1347.
21. Knox, K. K., Brewer, J. H., Henry, J. M., Harrington, D. J. and Carrigan, D. R. (2000) Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis, 31, pp. 894-903.
22. Levine, D. P., Lauter, C. B. and Lerner, A. M. (1978) Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA, 240, pp. 356-360.
23. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. B., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., Noort, S van den, Weinschenker, B. Y. and Wolinsky, J. S. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 50, pp. 121-127.
24. Moore, F GA and Wolfson, C. (2002) Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand, 106, pp. 63-83.
25. Panitch, H. S. (1994) Influence of infection on exacerbations of multiple sclerosis. Ann Neurol, 36, pp. S25-S28.
26. Rotola, A., Merlotti, I., Caniatti, L., Caselli, E., Granieri, E., Tola, M. R., Luca, D Di and Cassai, E. (2004) Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler, 10, pp. 348-354.
27. Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfeld, B., Wong-Staal, F., Kramarsky, P. and Gallo, R. C. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science, 234, pp. 596-600.
28. Salonen, M JH, Siimes, M. A., Salonen, E-M, Vaheri, A. and Koskiniemi, M. (2002) Antibody status to HHV-6 in children with leukaemia. Leukemia, 16, pp. 716-719.
29. Soldan, S. S., Leist, T. P., Juhng, K. N., McFarland, H. F. and Jacobson, S. (2000) Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol, 47, pp. 306-313.
30. Virtanen, J. O., Zabriskie, J. E., Sirén, V., Friedman, J. E., Lyons, M. J., Edgar, M., Vaheri, A. and Koskiniemi, M. (2005) Co-localization of human herpesvirus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med Sci Monit, 11, pp. BR84-BR87.
31. Ward, K. N., Andrews, N. J., Verity, C. M., Miller, E. and Ross, E. M. (2005) Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child, 90, pp. 619-623.
32. Ward, K. N., Gray, J. J., Fotheringham, M. W. and Sheldon, M. J. (1993) IgG antibodies to human herpesvirus-6 in young children in avidity of antibody correlate with time after infection. J Med Virol, 39, pp. 131-138.
33. Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. and Kurata, T. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet, pp. 1065-1067.